Stay updated with breaking news from Zyme Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer and pre|CISION platforms is pleased
Appointment of Dr Gary Clark as Head of Screening Technologies supports Metrion's cell biology initiative and introduction of new screening platforms Service capabilities expanded by addition
Investors include Y Combinator, Cantos Ventures, Lombard Street, Pi Campus and Angel investors, and non-dilutive funding has also been contributed by Innovate UK and the European Commission
New center brings local cell culture media optimization support for vaccines, advanced therapies, and biotherapeutic drug developmentSANTA ANA, Calif.--(BUSINESS WIRE)--FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free and chemically defined cell culture media for biop...
Appointment supports the next phase of growth within United States for ion channel contract research and drug discovery services Metrion Biosciences Limited ("Metrion"), the specialist ion channel